Latest News
Dr. Reddy's Laboratories Limited
- Four Stocks To Buy Today, October 22: Mphasis, Bharat Dynamics, Dr Reddy's Laboratories, Indian Hotels
- Dr. Reddy's Laboratories Limited expected to post earnings of ₹8.64 a share - Earnings Preview
- Dr Reddy’s Gets DCGI Approval for Zytorvi in Esophageal Cancer; Shares Rise 0.31%
- Dr Reddy’s Laboratories appoints Devang Mehta as Category Head – Marketing
- Dr Reddy’s Laboratories appoints Devang Mehta as Category Head – Marketing
- Dr Reddy’s formulations facility gets three observations from FDA
- Dr Reddy’s Laboratories Appoints Devang Mehta As Category Head Marketing
- Dr. Reddy's Laboratories falls Wednesday, underperforms competitors
- Dr Reddy’s Laboratories receives two observations for Andhra Pradesh facility
- Dr. Reddy’s facility in Andhra Pradesh gets 2 U.S. FDA observations
- Dr Reddy’s US arm faces $32,350 IRS penalty over fiscal year misclassification
- Dr Reddy's shares gain over 1% after Nomura retains 'Buy'; Rs1,740 target, key biologics milestones ahead
Headlines from the last 30 days, linking to the original publishers. See all market news →